Filter

Refine by date

—
  • Print
  • Save

Search Results

You are looking at 21 - 30 of 37 items for :

  • "incidence" x
Clear All
Christie G Turin Department of Medicine, Division of Endocrinology, Metabolism and Diabetes, University of Colorado, Aurora, Colorado, USA

Search for other papers by Christie G Turin in
Google Scholar
PubMed Close
,
Molly M Crenshaw Department of Pediatrics, Combined Pediatrics-Medical Genetics Residency Program, University of Colorado, Aurora, Colorado, USA

Search for other papers by Molly M Crenshaw in
Google Scholar
PubMed Close
, and
Lauren Fishbein Department of Medicine, Division of Endocrinology, Metabolism and Diabetes, University of Colorado, Aurora, Colorado, USA
Division of Biomedical Informatics and Personalized Medicine, University of Colorado School of Medicine, Aurora, Colorado, USA

Search for other papers by Lauren Fishbein in
Google Scholar
PubMed Close

= 26) was 25%, but clearly, the small sample size is a limitation to the study. Another recent retrospective case series that included 91 patients (46 probands) with confirmed SDHC PVs revealed that PCC/PGL incidence in non-probands by age 60 was 6

Article Type:
Review Article
DOI:
https://doi.org/10.1530/EO-22-0044
Volume/Issue:
Volume 2: Issue 1
Open access
Joel George Hampshire Hospitals NHS Trust, Basingstoke, United Kingdom of Great Britain and Northern Ireland

Search for other papers by Joel George in
Google Scholar
PubMed Close
,
John Ramage Hampshire Hospitals NHS Trust, Basingstoke, United Kingdom of Great Britain and Northern Ireland

Search for other papers by John Ramage in
Google Scholar
PubMed Close
,
Benjamin White Hampshire Hospitals NHS Trust, Basingstoke, United Kingdom of Great Britain and Northern Ireland

Search for other papers by Benjamin White in
Google Scholar
PubMed Close
, and
Rajaventhan Srirajaskanthan Kings Health Partners NET Centre of Excellence, London, United Kingdom of Great Britain and Northern Ireland

Search for other papers by Rajaventhan Srirajaskanthan in
Google Scholar
PubMed Close

presence of a clinical syndrome due to excessive hormone secretion, termed carcinoid syndrome (CS), denotes a functional NEN. Carcinoid syndrome The commonest syndrome caused by functional NENs is CS. It has an estimated overall incidence of 1 in

Article Type:
Review Article
DOI:
https://doi.org/10.1530/EO-22-0077
Volume/Issue:
Volume 3: Issue 1
Open access
Nadia Gagnon Division of Endocrinology, Department of Medicine, Centre de Recherche du Centre hospitalier de l’Université de Montréal (CRCHUM), Montreal, Quebec, Canada

Search for other papers by Nadia Gagnon in
Google Scholar
PubMed Close
,
Sophie Bernard Division of Endocrinology, Department of Medicine, Centre de Recherche du Centre hospitalier de l’Université de Montréal (CRCHUM), Montreal, Quebec, Canada
Lipids, Nutrition and Cardiovascular Prevention Clinic of the Montreal Clinical Research Institute, Montreal, Québec, Canada

Search for other papers by Sophie Bernard in
Google Scholar
PubMed Close
,
Martine Paquette Lipids, Nutrition and Cardiovascular Prevention Clinic of the Montreal Clinical Research Institute, Montreal, Québec, Canada

Search for other papers by Martine Paquette in
Google Scholar
PubMed Close
,
Catherine Alguire Division of Endocrinology, Department of Medicine, Centre de Recherche du Centre hospitalier de l’Université de Montréal (CRCHUM), Montreal, Quebec, Canada

Search for other papers by Catherine Alguire in
Google Scholar
PubMed Close
,
André Lacroix Division of Endocrinology, Department of Medicine, Centre de Recherche du Centre hospitalier de l’Université de Montréal (CRCHUM), Montreal, Quebec, Canada

Search for other papers by André Lacroix in
Google Scholar
PubMed Close
,
Pierre-Olivier Hétu Department of Biochemistry, Centre hospitalier de l’Université de Montréal (CHUM), Montreal, Quebec, Canada

Search for other papers by Pierre-Olivier Hétu in
Google Scholar
PubMed Close
,
Harold J Olney Department of Medicine, Centre hospitalier de l'Université de Montréal (CHUM), Montreal, Quebec, Canada

Search for other papers by Harold J Olney in
Google Scholar
PubMed Close
, and
Isabelle Bourdeau Division of Endocrinology, Department of Medicine, Centre de Recherche du Centre hospitalier de l’Université de Montréal (CRCHUM), Montreal, Quebec, Canada

Search for other papers by Isabelle Bourdeau in
Google Scholar
PubMed Close

Introduction Adrenocortical carcinoma (ACC) has an incidence of approximately 1–2 per million population per year ( Bourdeau et al. 2013 ). Staging at presentation remains one of the key prognostic factors with an expected 5-year survival of

Article Type:
Research Article
DOI:
https://doi.org/10.1530/EO-21-0021
Volume/Issue:
Volume 2: Issue 1
Open access
Patricia Gina Lu Department of General Surgery, Division of Surgical Oncology and Endocrine Surgery, Mayo Clinic in Arizona, Phoenix, Arizona, USA

Search for other papers by Patricia Gina Lu in
Google Scholar
PubMed Close
,
Zhi Ven Fong Department of General Surgery, Division of Surgical Oncology and Endocrine Surgery, Mayo Clinic in Arizona, Phoenix, Arizona, USA

Search for other papers by Zhi Ven Fong in
Google Scholar
PubMed Close
,
Patrick T Hangge Department of General Surgery, Division of Surgical Oncology and Endocrine Surgery, Mayo Clinic in Arizona, Phoenix, Arizona, USA

Search for other papers by Patrick T Hangge in
Google Scholar
PubMed Close
,
Yu-Hui Chang Department of Quantitative Health Sciences, Mayo Clinic in Arizona, Scottsdale, Arizona, USA

Search for other papers by Yu-Hui Chang in
Google Scholar
PubMed Close
,
Elisabeth S Lim Department of Quantitative Health Sciences, Mayo Clinic in Arizona, Scottsdale, Arizona, USA

Search for other papers by Elisabeth S Lim in
Google Scholar
PubMed Close
,
Nabil Wasif Department of General Surgery, Division of Surgical Oncology and Endocrine Surgery, Mayo Clinic in Arizona, Phoenix, Arizona, USA

Search for other papers by Nabil Wasif in
Google Scholar
PubMed Close
,
Patricia A Cronin Department of General Surgery, Division of Surgical Oncology and Endocrine Surgery, Mayo Clinic in Arizona, Phoenix, Arizona, USA

Search for other papers by Patricia A Cronin in
Google Scholar
PubMed Close
, and
Chee-Chee Stucky Department of General Surgery, Division of Surgical Oncology and Endocrine Surgery, Mayo Clinic in Arizona, Phoenix, Arizona, USA

Search for other papers by Chee-Chee Stucky in
Google Scholar
PubMed Close

Data source The SEER database comprises cancer incidence data from population-based cancer registries covering approximately 48% of the U.S. population. Unlike other cancer registries, the SEER database is not affiliated with specific hospitals or

Article Type:
Research Article
DOI:
https://doi.org/10.1530/EO-24-0010
Volume/Issue:
Volume 4: Issue 1
Open access
Leo Baxendale-Smith Department of Medical Oncology, Edinburgh Cancer Centre, Western General Hospital, Crewe Road, South, Edinburgh, United Kingdom

Search for other papers by Leo Baxendale-Smith in
Google Scholar
PubMed Close
,
Karim El-Shakankery Department of Medical Oncology, Edinburgh Cancer Centre, Western General Hospital, Crewe Road, South, Edinburgh, United Kingdom

Search for other papers by Karim El-Shakankery in
Google Scholar
PubMed Close
,
James Gordon-Smith Department of Interventional Radiology, Royal Infirmary of Edinburgh, Edinburgh, United Kingdom

Search for other papers by James Gordon-Smith in
Google Scholar
PubMed Close
, and
Lucy Wall Department of Medical Oncology, Edinburgh Cancer Centre, Western General Hospital, Crewe Road, South, Edinburgh, United Kingdom

Search for other papers by Lucy Wall in
Google Scholar
PubMed Close

2022, 12 years after the initial diagnosis and nine years after the diagnosis of metastatic disease. Discussion Adrenocortical carcinoma (ACC) is a rare malignancy with an incidence of one to two cases per million population per year. As such

Article Type:
Case Report
DOI:
https://doi.org/10.1530/EO-23-0041
Volume/Issue:
Volume 4: Issue 1
Open access
Katherine A English OCDEM, Radcliffe Department of Medicine, University of Oxford, Churchill Hospital, Oxford, UK

Search for other papers by Katherine A English in
Google Scholar
PubMed Close
,
Rajesh V Thakker OCDEM, Radcliffe Department of Medicine, University of Oxford, Churchill Hospital, Oxford, UK
Oxford NIHR Biomedical Research Centre, Oxford University Hospitals Trust, Oxford, UK

Search for other papers by Rajesh V Thakker in
Google Scholar
PubMed Close
, and
Kate E Lines OCDEM, Radcliffe Department of Medicine, University of Oxford, Churchill Hospital, Oxford, UK
Oxford NIHR Biomedical Research Centre, Oxford University Hospitals Trust, Oxford, UK

Search for other papers by Kate E Lines in
Google Scholar
PubMed Close

Introduction Pancreatic neuroendocrine tumours (PNETs) account for approximately 10% of all pancreatic tumours and occur with an incidence of approximately 1 per 100,000 ( Sonbol et al. 2022 ). The incidence of PNETs is rising, partly due to

Article Type:
Review Article
DOI:
https://doi.org/10.1530/EO-23-0003
Volume/Issue:
Volume 3: Issue 1
Open access
Vineeth Sukrithan Division of Medical Oncology, Department of Internal Medicine, The Ohio State University and Arthur G James Cancer Center, Columbus, Ohio, USA

Search for other papers by Vineeth Sukrithan in
Google Scholar
PubMed Close
,
Prachi Jain Division of Medical Oncology, Department of Internal Medicine, The Ohio State University and Arthur G James Cancer Center, Columbus, Ohio, USA

Search for other papers by Prachi Jain in
Google Scholar
PubMed Close
,
Manisha H Shah Division of Medical Oncology, Department of Internal Medicine, The Ohio State University and Arthur G James Cancer Center, Columbus, Ohio, USA

Search for other papers by Manisha H Shah in
Google Scholar
PubMed Close
, and
Bhavana Konda Division of Medical Oncology, Department of Internal Medicine, The Ohio State University and Arthur G James Cancer Center, Columbus, Ohio, USA

Search for other papers by Bhavana Konda in
Google Scholar
PubMed Close

refractory DTC and MTC have median 10-year survival rates of around 40–42% ( Durante et al. 2006 , Tuttle et al. 2010 , Giunti et al. 2013 ). Poorly DTCs (PDTCs) represent a subset with features that are in between DTC and ATC. The incidence is around

Article Type:
Review Article
DOI:
https://doi.org/10.1530/EO-22-0062
Volume/Issue:
Volume 3: Issue 1
Open access
Lucinda M Gruber Division of Endocrinology, Mayo Clinic, Rochester, Minnesota, USA

Search for other papers by Lucinda M Gruber in
Google Scholar
PubMed Close
,
Steven N Hart Department of Computational Pathology and Artificial Intelligence, Mayo Clinic, Rochester, Minnesota, USA

Search for other papers by Steven N Hart in
Google Scholar
PubMed Close
, and
Louis James Maher III Department of Biochemistry and Molecular Biology, Mayo Clinic, Rochester, Minnesota, USA

Search for other papers by Louis James Maher III in
Google Scholar
PubMed Close

& RARECAREnet working group 2020 Incidence and survival of rare cancers in the US and Europe . Cancer Medicine 9 5632 – 5642 . ( https://doi.org/10.1002/cam4.3137 ) Buffet A Burnichon N Favier J & Gimenez-Roqueplo AP 2020 An overview of 20 years of

Article Type:
Research Article
DOI:
https://doi.org/10.1530/EO-22-0093
Volume/Issue:
Volume 3: Issue 1
Open access
Molly Endicott University of Exeter Medical School, RILD Building, RD&E Hospital Wonford, Exeter, UK

Search for other papers by Molly Endicott in
Google Scholar
PubMed Close
,
Chrissie Thirlwell University of Exeter Medical School, RILD Building, RD&E Hospital Wonford, Exeter, UK

Search for other papers by Chrissie Thirlwell in
Google Scholar
PubMed Close
, and
Amy P Webster University of Exeter Medical School, RILD Building, RD&E Hospital Wonford, Exeter, UK

Search for other papers by Amy P Webster in
Google Scholar
PubMed Close

diabetes generally demonstrate lower prostate-specific antigen levels than individuals without diabetes. This is likely to reduce the detection and diagnosis of prostate cancer, which may also contribute to the reduced incidence of prostate cancer

Article Type:
Review Article
DOI:
https://doi.org/10.1530/EO-22-0094
Volume/Issue:
Volume 3: Issue 1
Open access
Yuko Matsuo Division of Endocrinology and Metabolism, Department of Internal Medicine, Kurume University School of Medicine, Asahi-machi, Kurume, Fukuoka, Japan

Search for other papers by Yuko Matsuo in
Google Scholar
PubMed Close
,
Kenji Ashida Division of Endocrinology and Metabolism, Department of Internal Medicine, Kurume University School of Medicine, Asahi-machi, Kurume, Fukuoka, Japan

Search for other papers by Kenji Ashida in
Google Scholar
PubMed Close
,
Ayako Nagayama Division of Endocrinology and Metabolism, Department of Internal Medicine, Kurume University School of Medicine, Asahi-machi, Kurume, Fukuoka, Japan

Search for other papers by Ayako Nagayama in
Google Scholar
PubMed Close
,
Kanoko Moritaka Division of Endocrinology and Metabolism, Department of Internal Medicine, Kurume University School of Medicine, Asahi-machi, Kurume, Fukuoka, Japan

Search for other papers by Kanoko Moritaka in
Google Scholar
PubMed Close
,
Mizuki Gobaru Division of Endocrinology and Metabolism, Department of Internal Medicine, Kurume University School of Medicine, Asahi-machi, Kurume, Fukuoka, Japan

Search for other papers by Mizuki Gobaru in
Google Scholar
PubMed Close
,
Junichi Yasuda Division of Endocrinology and Metabolism, Department of Internal Medicine, Kurume University School of Medicine, Asahi-machi, Kurume, Fukuoka, Japan

Search for other papers by Junichi Yasuda in
Google Scholar
PubMed Close
,
Naoyuki Ogasawara Department of Urology, Kurume University School of Medicine, Asahi-machi, Kurume, Fukuoka, Japan

Search for other papers by Naoyuki Ogasawara in
Google Scholar
PubMed Close
,
Hirofumi Kurose Department of Urology, Kurume University School of Medicine, Asahi-machi, Kurume, Fukuoka, Japan

Search for other papers by Hirofumi Kurose in
Google Scholar
PubMed Close
,
Katsuaki Chikui Department of Urology, Kurume University School of Medicine, Asahi-machi, Kurume, Fukuoka, Japan

Search for other papers by Katsuaki Chikui in
Google Scholar
PubMed Close
,
Shimpei Iwata Division of Endocrinology and Metabolism, Department of Internal Medicine, Kurume University School of Medicine, Asahi-machi, Kurume, Fukuoka, Japan

Search for other papers by Shimpei Iwata in
Google Scholar
PubMed Close
,
Yukihiro Inoguchi Division of Endocrinology and Metabolism, Department of Internal Medicine, Kurume University School of Medicine, Asahi-machi, Kurume, Fukuoka, Japan

Search for other papers by Yukihiro Inoguchi in
Google Scholar
PubMed Close
,
Nao Hasuzawa Division of Endocrinology and Metabolism, Department of Internal Medicine, Kurume University School of Medicine, Asahi-machi, Kurume, Fukuoka, Japan

Search for other papers by Nao Hasuzawa in
Google Scholar
PubMed Close
,
Seiichi Motomura Division of Endocrinology and Metabolism, Department of Internal Medicine, Kurume University School of Medicine, Asahi-machi, Kurume, Fukuoka, Japan

Search for other papers by Seiichi Motomura in
Google Scholar
PubMed Close
,
Tsukasa Igawa Department of Urology, Kurume University School of Medicine, Asahi-machi, Kurume, Fukuoka, Japan

Search for other papers by Tsukasa Igawa in
Google Scholar
PubMed Close
, and
Masatoshi Nomura Division of Endocrinology and Metabolism, Department of Internal Medicine, Kurume University School of Medicine, Asahi-machi, Kurume, Fukuoka, Japan

Search for other papers by Masatoshi Nomura in
Google Scholar
PubMed Close

.psym.2013.08.008 ) Araki S Kijima T Waseda Y Komai Y Nakanishi Y Uehara S Yasuda Y Yoshida S Yokoyama M Ishioka J , 2019 Incidence and predictive factors of hypoglycemia after pheochromocytoma resection . International Journal of

Article Type:
Research Article
DOI:
https://doi.org/10.1530/EO-23-0006
Volume/Issue:
Volume 3: Issue 1
Open access